Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Wyeth |
---|---|
Information provided by: | Wyeth |
ClinicalTrials.gov Identifier: | NCT00401219 |
This study will compare the bioavailabity of three new investigational combination formulations of Premarin and medroxyprogesterone acetate (MPA) with a currently marketed formulation of Premarin and MPA, Prempro™. Prempro™ is indicated for use after menopause in women with a uterus to reduce moderate to severe hot flashes; to treat moderate to severe dryness, itching, and burning, in and around the vagina; and to help reduce your chances of getting osteoporosis (thin weak bones). The purpose of this study is to determine if these new formulations of Premarin/MPA provide the same levels of estrogen and MPA in the blood as Prempro in healthy postmenopausal women.
Condition | Intervention | Phase |
---|---|---|
Estrogen Replacement Therapy |
Drug: conjugated estrogens/progestin (MPA) |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Crossover Assignment, Bio-availability Study |
Official Title: | An Open-Label, Single-Dose, Randomized, 4-Period, Crossover, Bioavailability Study Among 3 New Formulations of Premarin 0.625 mg/Medroxyprogesterone Acetate (Mpa) 2.5 mg Compared With a Reference Formulation of Premarin/Mpa (Prempro) 0.625 mg/2.5 mg in Healthy Postmenopausal Women |
Study Start Date: | November 2006 |
Study Completion Date: | February 2007 |
Ages Eligible for Study: | 35 Years to 70 Years |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Study ID Numbers: | 0713E1-136 |
Study First Received: | November 17, 2006 |
Last Updated: | December 4, 2007 |
ClinicalTrials.gov Identifier: | NCT00401219 |
Health Authority: | United States: Institutional Review Board |
Estrogens, Conjugated (USP) Medroxyprogesterone 17-Acetate Medroxyprogesterone Healthy |
Estrogens Antineoplastic Agents, Hormonal Antineoplastic Agents Contraceptive Agents Therapeutic Uses Physiological Effects of Drugs |
Contraceptive Agents, Female Hormones, Hormone Substitutes, and Hormone Antagonists Reproductive Control Agents Contraceptive Agents, Male Hormones Pharmacologic Actions |